Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

listen audio

Study Justification:
The study aims to measure progress on the health-related Sustainable Development Goals (SDGs) from 1990 to 2017 and project attainment to 2030 for 195 countries and territories. By examining the health-related SDGs beyond national-level estimates, the study seeks to identify areas where improvements can be made to ensure that no one is left behind. The study provides valuable information for policymakers and stakeholders to guide interventions and investments in order to achieve the SDGs.
Highlights:
– The study measured progress on 41 health-related SDG indicators and constructed a health-related SDG index for 195 countries and territories.
– Global median health-related SDG index in 2017 was 59.4, ranging from 11.6 to 84.9.
– Indicators varied by sex and socio-demographic index quintile, with males having worse outcomes for certain indicators.
– Most countries were projected to have a higher health-related SDG index in 2030 compared to 2017.
– Under-5 mortality, neonatal mortality, maternal mortality ratio, and malaria indicators had the most countries with at least 95% probability of target attainment.
– Some indicators, such as child malnutrition and infectious diseases, require a faster pace of progress to meet the SDG targets.
Recommendations:
– Increase collection and analysis of disaggregated data to better monitor progress on the health-related SDGs.
– Design and target interventions to accelerate progress in attaining the SDGs, particularly for indicators that require a concerted shift towards prevention-oriented policies and investments.
– Address the challenges posed by indicators that demand a pace of progress that no country has achieved in the recent past.
– Emphasize multisectoral approaches and prevention-oriented policies to achieve the SDG aims.
Key Role Players:
– Policymakers and government officials responsible for health and development planning.
– International organizations and agencies involved in global health and development.
– Non-governmental organizations (NGOs) working on health and development issues.
– Researchers and academics specializing in global health and sustainable development.
– Community leaders and advocates for health and development.
Cost Items:
– Data collection and analysis: Includes costs associated with collecting and analyzing disaggregated data for monitoring progress on the health-related SDGs.
– Intervention design and implementation: Budget items for designing and implementing interventions targeted at accelerating progress towards the SDG targets.
– Capacity building: Investments in training and capacity building for health workers and policymakers to effectively address the SDG targets.
– Research and innovation: Funding for research and innovation to develop new approaches and technologies to achieve the SDGs.
– Advocacy and awareness campaigns: Budget items for raising awareness and advocating for the importance of the health-related SDGs.
– Monitoring and evaluation: Costs associated with monitoring and evaluating the impact of interventions and progress towards the SDG targets.

The strength of evidence for this abstract is 9 out of 10.
The evidence in the abstract is strong because it is based on the Global Burden of Disease Study 2017, which is a comprehensive and widely recognized study. The study uses robust methods and data sources to estimate health-related Sustainable Development Goals (SDGs) for 195 countries and territories. The abstract provides detailed information on the methods used, including the measurement of indicators, construction of the SDG index, and projections to 2030. The findings are presented clearly, with specific values and ranges provided for the health-related SDG index and individual indicators. The abstract also highlights the challenges and areas for improvement in achieving the SDGs. To improve the evidence, the abstract could provide more information on the limitations of the study and potential sources of bias.

Background: Efforts to establish the 2015 baseline and monitor early implementation of the UN Sustainable Development Goals (SDGs) highlight both great potential for and threats to improving health by 2030. To fully deliver on the SDG aim of “leaving no one behind”, it is increasingly important to examine the health-related SDGs beyond national-level estimates. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017), we measured progress on 41 of 52 health-related SDG indicators and estimated the health-related SDG index for 195 countries and territories for the period 1990–2017, projected indicators to 2030, and analysed global attainment. Methods: We measured progress on 41 health-related SDG indicators from 1990 to 2017, an increase of four indicators since GBD 2016 (new indicators were health worker density, sexual violence by non-intimate partners, population census status, and prevalence of physical and sexual violence [reported separately]). We also improved the measurement of several previously reported indicators. We constructed national-level estimates and, for a subset of health-related SDGs, examined indicator-level differences by sex and Socio-demographic Index (SDI) quintile. We also did subnational assessments of performance for selected countries. To construct the health-related SDG index, we transformed the value for each indicator on a scale of 0–100, with 0 as the 2·5th percentile and 100 as the 97·5th percentile of 1000 draws calculated from 1990 to 2030, and took the geometric mean of the scaled indicators by target. To generate projections through 2030, we used a forecasting framework that drew estimates from the broader GBD study and used weighted averages of indicator-specific and country-specific annualised rates of change from 1990 to 2017 to inform future estimates. We assessed attainment of indicators with defined targets in two ways: first, using mean values projected for 2030, and then using the probability of attainment in 2030 calculated from 1000 draws. We also did a global attainment analysis of the feasibility of attaining SDG targets on the basis of past trends. Using 2015 global averages of indicators with defined SDG targets, we calculated the global annualised rates of change required from 2015 to 2030 to meet these targets, and then identified in what percentiles the required global annualised rates of change fell in the distribution of country-level rates of change from 1990 to 2015. We took the mean of these global percentile values across indicators and applied the past rate of change at this mean global percentile to all health-related SDG indicators, irrespective of target definition, to estimate the equivalent 2030 global average value and percentage change from 2015 to 2030 for each indicator. Findings: The global median health-related SDG index in 2017 was 59·4 (IQR 35·4–67·3), ranging from a low of 11·6 (95% uncertainty interval 9·6–14·0) to a high of 84·9 (83·1–86·7). SDG index values in countries assessed at the subnational level varied substantially, particularly in China and India, although scores in Japan and the UK were more homogeneous. Indicators also varied by SDI quintile and sex, with males having worse outcomes than females for non-communicable disease (NCD) mortality, alcohol use, and smoking, among others. Most countries were projected to have a higher health-related SDG index in 2030 than in 2017, while country-level probabilities of attainment by 2030 varied widely by indicator. Under-5 mortality, neonatal mortality, maternal mortality ratio, and malaria indicators had the most countries with at least 95% probability of target attainment. Other indicators, including NCD mortality and suicide mortality, had no countries projected to meet corresponding SDG targets on the basis of projected mean values for 2030 but showed some probability of attainment by 2030. For some indicators, including child malnutrition, several infectious diseases, and most violence measures, the annualised rates of change required to meet SDG targets far exceeded the pace of progress achieved by any country in the recent past. We found that applying the mean global annualised rate of change to indicators without defined targets would equate to about 19% and 22% reductions in global smoking and alcohol consumption, respectively; a 47% decline in adolescent birth rates; and a more than 85% increase in health worker density per 1000 population by 2030. Interpretation: The GBD study offers a unique, robust platform for monitoring the health-related SDGs across demographic and geographic dimensions. Our findings underscore the importance of increased collection and analysis of disaggregated data and highlight where more deliberate design or targeting of interventions could accelerate progress in attaining the SDGs. Current projections show that many health-related SDG indicators, NCDs, NCD-related risks, and violence-related indicators will require a concerted shift away from what might have driven past gains—curative interventions in the case of NCDs—towards multisectoral, prevention-oriented policy action and investments to achieve SDG aims. Notably, several targets, if they are to be met by 2030, demand a pace of progress that no country has achieved in the recent past. The future is fundamentally uncertain, and no model can fully predict what breakthroughs or events might alter the course of the SDGs. What is clear is that our actions—or inaction—today will ultimately dictate how close the world, collectively, can get to leaving no one behind by 2030. Funding: Bill & Melinda Gates Foundation.

Each year, the GBD study produces age-specific, sex-specific, and location-specific estimates of all-cause and cause-specific mortality, non-fatal outcomes, overall disease burden (ie, disability-adjusted life-years), and risk factor exposure and attributable burden from 1990 to the current study year. This analysis of the health-related SDGs is based on GBD 2017 estimates. Broader GBD 2017 methods are described elsewhere,21, 23, 24, 25, 26, 27 while further detail on data sources and estimation approaches used for this analysis are available in appendix 1 (part 1). We used previously established GBD methods to generate indicator-specific estimates for 1990–2017, including the Cause of Death Ensemble model for causes of death,23, 28 DisMod-MR for many non-fatal causes,26, 29 and spatiotemporal Gaussian process regression for most risk factor exposures, measures of intervention coverage, and other SDG indicators (eg, well-certified death registration [SDG indicator 17.19.2c]).21, 30 Each year, GBD includes subnational analyses for a few new countries and continues to provide subnational estimates for countries that were added in previous cycles. Subnational estimation in GBD 2017 includes five new countries (Ethiopia, Iran, New Zealand, Norway, Russia) and countries previously estimated at subnational levels (GBD 2013: China, Mexico, and the UK [regional level]; GBD 2015: Brazil, India, Japan, Kenya, South Africa, Sweden, and the USA; GBD 2016: Indonesia and the UK [local government authority level]). All analyses are at the first level of administrative organisation within each country except for New Zealand (by Māori ethnicity), Sweden (by Stockholm and non-Stockholm), and the UK (by local government authorities). All subnational estimates for these countries were incorporated into model development and evaluation as part of GBD 2017. To meet data use requirements, in this publication we present all subnational estimates excluding those pending publication (Brazil, India, Japan, Kenya, Mexico, Sweden, the UK, and the USA); these results are presented in appendix tables and figures (appendix 2). Subnational estimates for countries with populations larger than 200 million (as measured with our most recent year of published estimates) that have not yet been published elsewhere are presented wherever estimates are illustrated with maps, but are not included in data tables. The GBD study uses standardised and replicable methods that comply with the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER).31 Analyses were done with R version 3.4.4, Python version 2.7.14, or Stata version 13.1. The entire GBD time series is updated annually with improved methods and data sources, and thus GBD 2017 findings, including the SDG analysis presented here, supersede all previous GBD publications. The health-related SDG indicators are shown in table 1. GBD 2017 assesses four more indicators than assessed in GBD 2016. The first is health worker density (SDG indicator 3.c.1), which is defined by the UN as health workers per 1000 population, by cadre of health worker. For this analysis, we report estimates for three main groups of health workers: physicians, nurses and midwives, and pharmacists. We used International Standard Classification of Occupations (ISCO) 88 to map cadres of health workers from multiple data sources and coding systems, resulting in comparable and consistently defined groupings of health workers over time and across locations (appendix 1 part 1). Health-related goals, targets, and SDG indicators Detailed descriptions of the data and methods used to estimate each of the 41 health-related SDG indicators included in the GBD 2017 study are located in appendix 1. For the 11 indicators currently not measured by GBD, additional information about data and measurement needs are provided in this table. DALY=disability-adjusted life-year. DPT=diphtheria-pertussis-tetanus. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study. IHR=International Health Regulations. IOTF=International Obesity Task Force. NCDs=non-communicable diseases. PM2·5=fine particulate matter smaller than 2·5 μm. SDG=Sustainable Development Goal. SEV=summary exposure value. TRIPS=World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights. UHC=universal health coverage. WaSH=water, sanitation, and hygiene. The second new indicator is sexual violence by non-intimate partners (SDG indicator 5.2.2), which is defined as the prevalence of females aged 15 years and older who have been subjected to sexual violence by non-intimate partners in the past 12 months. The third is the separate reporting of the prevalence of physical and sexual violence (SDG indicator 16.1.3). In March, 2018, the UN Statistical Commission approved refinements to SDG indicator 16.1.3, such that the indicator is now defined as the “proportion of population subjected to (a) physical violence, (b) psychological violence, and (c) sexual violence in the previous 12 months”.32, 33 Following the GBD precedent of measuring each component of an SDG indicator (eg, reporting separately on child wasting and overweight [SDG indicators 2.2.2a and 2.2.2b] and on sanitation and access to handwashing facilities [SDG indicators 6.2.1a and 6.2.1b]),5, 13 we report the prevalence of physical violence and that of sexual violence separately. Owing to measurement challenges and data sparsity, we did not measure the prevalence of psychological violence. The final new indicator is population census status (SDG indicator 17.19.2a), which was defined as covered if a location had conducted a population and housing census within the past 10 years or had an established population registry that routinely captured nationally representative demographic information (appendix 1 part 1). To assess population census status, we used data compiled for GBD 2017 population estimates,24 as well as all available data on population census implementation since 1980 and documentation of population registries. As well as adding new indicators, we have improved the measurement of several previously reported indicators. For smoking prevalence (SDG indicator 3.a.1), we now report prevalence of current smoking (daily and occasional smokers) rather than only daily smoking to better align with the UN’s definition (appendix 1 part 1). For vaccine coverage (SDG indicator 3.b.1), we include all eight vaccines in the aggregate measure for each location-year, rather than limiting the aggregate to vaccines expressly included in national vaccine schedules. Additionally, we now take the arithmetic, rather than the geometric, mean across the eight vaccines. These revisions allow better comparability across locations over time, avoid inadvertently penalising countries for introducing and scaling up new vaccines, and provide a better reflection of overall vaccine coverage for target populations. The UHC service coverage index includes nine measures of coverage for a subset of interventions for communicable diseases and maternal and child health and the 32 causes that comprise the Healthcare Access and Quality (HAQ) Index (appendix 1 part 1). The HAQ Index is an overall measure of health-care access and quality based on risk-standardised death rates or mortality-to-incidence ratios from causes amenable to health care.34 Following updated HAQ methods,34 we used mortality-to-incidence ratios for cancers rather than risk-standardised death rates for the UHC service coverage index to better approximate access to quality cancer care. Considerable updates were made to measurement of adolescent birth rate (SDG indicator 3.7.2), which was based on comprehensive estimates of population and fertility from GBD 2017,24 as well as of fatal discontinuities (mortality due to natural disasters or conflict and terrorism), among other indicators. Further detail can be found in appendix 1 (part 1) and accompanying GBD 2017 papers.21, 23, 24, 25, 26, 27 We report estimates for all health-related SDG indicators with both sexes combined and sex-specific estimates for HIV incidence (SDG indicator 3.3.1), tuberculosis incidence (SDG indicator 3.3.2), hepatitis B incidence (SDG indicator 3.3.4), NCD mortality (SDG indicator 3.4.1), suicide mortality (SDG indicator 3.4.2), alcohol use (SDG indicator 3.5.2), road injury mortality (SDG indicator 3.6.1), poisoning mortality (SDG indicator 3.9.3), smoking prevalence (SDG 3.a.1), and homicide (SDG indicator 16.1.1). We selected indicators for sex-specific analysis according to the availability of GBD sex-specific data and the utility of presenting sex-specific data by indicator. We used SDI,35 a composite measure of overall development based on rescaled values of fertility, education, and income, to compare performance on the health-related SDGs across quintiles of overall development. For GBD 2017, SDI was updated to include only fertility rates for females younger than 25 years rather than total fertility rates.24 The GBD 2017 population and fertility analysis found that total fertility demonstrates a U-shaped pattern with SDI at higher levels of development, whereas fertility in females younger than 25 years does not.24 Quintile breaks were generated from the distribution of SDI at the national level in countries with populations greater than 1 million applied to all 195 locations. A complete list of SDI quintiles by location are available in appendix 1.24 To generate projections to 2030, we used forecasting methods developed by Foreman and colleagues that produced reference forecasts and alternative health scenarios for life expectancy, all-cause mortality, and cause-specific mortality.36 The modelling framework was designed to account for the relationships between risk factors and other independent drivers of health outcomes (eg, gains in sociodemographic development, select interventions such as vaccine coverage, and met need for family planning), thus better capturing causal pathways of health change shown in randomised controlled trials and cohort studies. We generated projections for independent drivers by calculating the annual change in each location and year from 1990 to 2017 in logit or natural-log space, and then computing weighted annualised rates of change. If weights were closer to zero, annual rates of change over time were more equally weighted across years; if weights were closer to higher values, recent years were more heavily weighted than were earlier years. These weights were selected through out-of-sample predictive validity tests; further details on the overarching forecasting framework and weight selection are in appendix 1 (part 3). Some causes (eg, natural disasters, conflict and terrorism, and HIV) required model modifications or alternative estimation strategies to account for either their stochastic nature or, in the case of HIV, unique sensitivity to intervention coverage (see appendix 1 part 3, and elsewhere36). Some indicators were inputs or outputs of the forecasting platform; for others, we used the weighted annualised rate of change method to produce projections to 2030 (appendix 1 part 3). For the UHC service coverage index, a modified version of the overarching forecasting framework was used, modelling the relationship between total health spending per capita and the UHC service coverage index with stochastic frontier analysis.37 We did not generate projections of census coverage because of its binary nature and the lack of documentation about planned censuses across all countries. Additionally, we do not currently project indicators by sex or subnationally. The health-related SDG index was originally developed in GBD 2015.13 The overall index for GBD 2017 consisted of 40 health-related SDG indicators (population census coverage was not included because of its binary status and because it does not have forecasts). To create the health-related SDG index, we used a preference-weighted approach in which we considered the SDGs as representing the expressed preferences of UN member states and thus assumed that each SDG target should be weighted equally. Each indicator was scaled to a value from 0 to 100, reflecting worst to best performance, to enable optimal comparison across diverse indicators, with 0 being the 2·5th percentile value and 100 being the 97·5th percentile value of 1000 observed or projected draws over the period 1990–2030. This approach reduced sensitivity to extreme outliers in given location-years. Negative indicators, for which lower values were more desirable than higher values (ie, mortality, incidence or prevalence, and risk exposure), were assigned 100 for the 2·5th percentile and 0 for the 97·5th percentile. For mortality and incidence, values were scaled in log-space. We calculated the geometric mean of scaled health-related SDG indicators by target, and then took the geometric mean across all health-related SDG targets to produce the overall health-related SDG index. We used the geometric mean to allow for partial substitutability (ie, permitting high values for some indicators to only partially compensate for indicators with very low values). We restricted indicators to a minimum value of 1 when calculating the overall index to mitigate issues with values close to 0. To generate subnational SDG indices, we used the national-level 2·5th and 97·5th percentile values for each indicator to scale indicators for each subnational location. We used the same overall index construction methods for national and subnational locations. For health worker density (SDG indicator 3.c.1), we used a modified scaling approach to reflect the importance of each health worker cadre (physicians, nurses and midwives, and pharmacists). On the basis of logistic regressions between each cadre and the HAQ Index,34 we identified the values at which additional increases in health worker density resulted in diminishing returns on the HAQ Index.34 In per 10 000 population space, these threshold values were 30 physicians, 100 nurses and midwives, and five pharmacists (appendix 1 part 1). Although we used the 2·5th percentile value of 1000 draws observed or projected from 1990 to 2030 to set the 0 threshold for all three cadres of health workers, we used cadre-specific thresholds to set the bounds for a 100 score rather than the 97·5th percentile of 1000 draws. We then took the geometric mean of scaled scores across the three cadres to estimate overall performance on the health worker density indicator. Some health-related SDG indicators have targets explicitly defined by UN resolution 71/313,38 including absolute targets and targets set in relation to 2015 values, whereas some indicators have undefined targets. In this analysis, 25 indicators had defined targets, for which we applied corresponding thresholds to analyse 2030 attainment (2020 in the case of road injury mortality, as set by the UN). For indicators with targets related to universal coverage or access, we set thresholds as 99%, whereas for indicators with targets related to achieving elimination or ending epidemics, we set thresholds as an incidence of 0·5 per 100 000 population or less or a prevalence of 0·5% or less. Thresholds or relative reductions for each target are shown in table 1. For GBD 2017, we estimated the probability of each country attaining health-related SDG indicators with defined targets. We used our indicator projections to 2030 at the draw level (1000 draws in total), calculating at each draw whether or not a country would attain a target. The total probability of attainment was the number of draws in which the country would attain the target divided by the total number of draws. We also calculated the mean estimate in 2030 (the average of 1000 draws), and used that estimate to assess whether or not a country would attain a target. Consequently, countries could have some probability of attainment for given targets despite not having projected attainment at the mean level. We also used past rates of change observed before the SDG era (ie, 1990–2015, or the monitoring period of the Millennium Development Goals) to analyse the feasibility of attaining SDG indicator targets in 2030. For SDG indicators with defined targets, we compared country-level annualised rates of change for 1990–2015 (ie, what has been achieved in the past) with the global pace of progress required to meet targets during the SDG era (2015–30) based on 2015 global estimates for each indicator; these estimates were derived from population-weighted means. For each indicator, we compared the required global annualised rate of change for 2015–30 against the distribution of past country-level annualised rates of change, and calculated in which percentile of performance the global required annualised rate of change would fall. We took the mean of those percentiles across the 25 indicators with defined targets and found that, on average, the required global annualised rates of change for 2015–30 would be in the 90th percentile of performance compared with the country-level annualised rates of change for 1990–2015. To see what global progress could be achieved if performance on all indicators was projected at that level from 2015 to 2030, we calculated the annualised rate of change required to meet the 90th percentile for each indicator, including those without defined targets, and projected the 2030 value and corresponding percentage change from 2015 to 2030 based on these annualised rates of change. For all indicator estimates, GBD 2017 produced 1000 draws by location, age, and sex and for all years. Draws from the posterior distribution represent uncertainty in steps in the estimation process as well as in underlying data sources. For each scaled SDG indicator and the health-related SDG index, we calculated 95% uncertainty intervals (UIs) on the basis of these 1000 draws using simulation analysis. Further information about GBD uncertainty analysis is provided in related GBD publications.21, 23, 24, 25, 26, 27 The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.

Based on the provided information, it is difficult to identify specific innovations for improving access to maternal health. The text you provided is a detailed description of the methods and findings of the Global Burden of Disease Study 2017, which measures progress on health-related Sustainable Development Goals (SDGs) for 195 countries and territories.

To identify innovations for improving access to maternal health, it would be helpful to focus on specific areas such as technology, healthcare delivery models, or policy interventions. Additionally, it would be beneficial to review research, reports, and initiatives specifically related to maternal health to identify potential innovations.

If you have any specific questions or areas of interest related to innovations for improving access to maternal health, please let me know and I will be happy to provide more targeted information.
AI Innovations Description
The recommendation to improve access to maternal health based on the information provided is to focus on the following areas:

1. Increase investment in healthcare infrastructure: To improve access to maternal health, it is crucial to invest in healthcare infrastructure, including hospitals, clinics, and health centers. This will ensure that pregnant women have access to quality healthcare facilities and skilled healthcare professionals during pregnancy, childbirth, and postpartum.

2. Strengthen healthcare workforce: There is a need to train and deploy more healthcare workers, particularly midwives and obstetricians, in areas with limited access to maternal health services. This will help ensure that pregnant women receive the necessary care and support throughout their pregnancy and childbirth.

3. Improve transportation and logistics: Many pregnant women in remote areas face challenges in accessing healthcare facilities due to lack of transportation. It is important to improve transportation infrastructure and provide reliable transportation services to ensure that pregnant women can reach healthcare facilities in a timely manner.

4. Enhance community-based healthcare services: Community-based healthcare services, such as mobile clinics and community health workers, can play a crucial role in improving access to maternal health. These services can provide prenatal care, education, and support to pregnant women in their own communities, reducing the need for long-distance travel.

5. Increase awareness and education: Promoting awareness and education about maternal health is essential to ensure that pregnant women understand the importance of seeking timely and appropriate healthcare. This can be achieved through community outreach programs, educational campaigns, and the use of technology, such as mobile apps and text messaging, to disseminate information.

6. Address socio-economic barriers: Socio-economic factors, such as poverty and lack of education, can hinder access to maternal health services. It is important to address these barriers by implementing social protection programs, providing financial assistance for healthcare expenses, and promoting girls’ education to empower women and improve their access to healthcare.

By focusing on these recommendations, it is possible to develop innovative solutions that can improve access to maternal health and contribute to achieving the Sustainable Development Goals related to maternal health.
AI Innovations Methodology
To improve access to maternal health, here are some potential recommendations:

1. Telemedicine: Implement telemedicine programs that allow pregnant women in remote or underserved areas to consult with healthcare professionals through video calls or mobile apps. This can provide access to prenatal care, advice, and monitoring without the need for physical travel.

2. Mobile clinics: Set up mobile clinics that travel to rural or remote areas to provide maternal health services. These clinics can offer prenatal check-ups, vaccinations, and education on maternal health practices.

3. Community health workers: Train and deploy community health workers who can provide basic maternal health services, education, and support in local communities. These workers can help identify high-risk pregnancies, provide antenatal care, and refer women to appropriate healthcare facilities.

4. Maternal health vouchers: Introduce voucher programs that provide pregnant women with financial assistance to access maternal health services. These vouchers can cover costs for prenatal care, delivery, and postnatal care, ensuring that women can afford the necessary healthcare.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could include the following steps:

1. Define indicators: Identify key indicators to measure the impact of the recommendations, such as the number of pregnant women accessing prenatal care, the reduction in maternal mortality rates, or the increase in skilled birth attendance.

2. Data collection: Gather data on the current state of maternal health access, including the number of pregnant women receiving care, maternal mortality rates, and other relevant indicators. This data can come from surveys, health records, or existing databases.

3. Baseline assessment: Establish a baseline for each indicator to understand the current level of access to maternal health services.

4. Model development: Develop a simulation model that incorporates the potential impact of the recommendations. This model can consider factors such as population demographics, geographic distribution, healthcare infrastructure, and the effectiveness of the proposed interventions.

5. Scenario analysis: Run simulations using different scenarios to assess the potential impact of each recommendation. This can involve varying parameters such as the number of telemedicine consultations, the frequency of mobile clinic visits, or the coverage of community health workers.

6. Impact assessment: Analyze the results of the simulations to determine the projected impact of the recommendations on improving access to maternal health. This can include quantifying changes in the indicators identified in step 1.

7. Sensitivity analysis: Conduct sensitivity analysis to assess the robustness of the results and identify key factors that may influence the outcomes. This can help understand the potential limitations or uncertainties associated with the simulations.

8. Policy recommendations: Based on the simulation results, provide policy recommendations on the most effective interventions to improve access to maternal health. Consider factors such as cost-effectiveness, scalability, and feasibility of implementation.

By following this methodology, policymakers and stakeholders can gain insights into the potential impact of different innovations and interventions on improving access to maternal health. This can inform decision-making and resource allocation to prioritize the most effective strategies.

Partilhar isto:
Facebook
Twitter
LinkedIn
WhatsApp
Email